跳至主要内容
临床试验/EUCTR2011-000233-37-SE
EUCTR2011-000233-37-SE进行中(未招募)不适用

Insulin-like Growth Factor (IGF-I) induced muscle glucose uptake and interstitial IGF-1 concentrations. Placebo controlled, crossover study of the effect of sc rhIGF-I(Increlex) administration on glucose infusion rate (whole body glucose utilization) and interstitial muscle IGF-1 concentrations under euglycemic clamp conditions in T1DM adolescents and young adults - IGF-I induced muscle glucose uptake and interstitial IGF-I concentrations

Stockholm Läns Landsting, Karolinska University Hospital0 个研究点目标入组 8 人开始时间: 2011年1月27日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Type 1 diabetes duration at least two years and assumed C-peptide negativity
  • 2. Chronological age from 16 to 25 years
  • 3. Tanner stage > 4 (Girls: Tanner B4 or more, Boys: Testis > 15 ml)
  • 4. Levemir or Lantus or Insulatard as basal analogue or CSII
  • 5. IGF-1 < -1.0 SDS and HbA1C < 73 mmol/l with screening or within past three months
  • 6. Written informed consent
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Development of hypoglycemia that can not be controlled with increased glucose infusion-rate

研究者

发起方
Stockholm Läns Landsting, Karolinska University Hospital

相似试验

尚未招募
不适用
Changes in Hormones: Does consuming protein or exercising influence the hormones of healthy adults?
ACTRN12618001919202Assoc Prof Nancy Rehrer24
尚未招募
Unknown
In this study healthy children and adolescents of 5-16 years are group are taken to determine chronological age bone age and correlate them with serum IGF-1 levels.
CTRI/2024/05/067782Jawaharlal Nehru Medical College, KLE University, Belagavi
Enrolling By Invitation
不适用
Expression of insulin-like growth factors as a prognostic factor in solitary fibrous tumorsICD-10-CM Z85.110 Personal history of malignant carcinoid tumor of bronchus and lung
DRKS00021109niversitätsklinikum Freiburg Klinik für Thoraxchirurgie100
进行中(未招募)
不适用
Recombinant Human Insulin-like Growth Factor (rhIGF-1) and Growth Hormone (rhGH) Combination Therapy of Pre-Pubertal Children with Idiopathic Growth Hormone Deficiency and Poor Response to First Year of Growth Hormone Therapy: A Phase II, Prospective, Randomized, Open-label, Multi-Centre, Parallel Group Add-On Study Comparing a Flexible rhIGF-1 Dose and Fixed rhGH Dose vs. Fixed rhGHDose Therapy.Pre-Pubertal Children with Idiopathic Growth Hormone DeficiencyMedDRA version: 12.1Level: LLTClassification code 10056438Term: Growth hormone deficiency
EUCTR2010-020742-10-GBIpsen Pharma63
进行中(未招募)
不适用
Comparison of efficacy and safety of Nutropin (rhGH) associated with Increlex (rhIGF-1) vs Nutropin (rhGH) alone [COGROW].Pre-Pubertal Children with Idiopathic Growth Hormone Deficiency and with poor response after one year of treatment.MedDRA version: 13.1Level: PTClassification code 10056438Term: Growth hormone deficiencySystem Organ Class: 10014698 - Endocrine disorders
EUCTR2010-020742-10-SEIpsen Pharma63
Insulin-like Growth Factor (IGF-I) induced muscle... | 临床试验